Skip to main content

The Medicines Development Research Group develops novel materials, formulations, drug delivery devices, manufacturing, analytical and digital technologies. Our metier is translational research through which our scientific expertise is used to turn drugs into medicines that provide real-world benefits for patients. The group have strong links with the world’s best universities, the pharmaceutical industry internationally and local teaching hospitals through King’s Health Partners.

Our key activities are focussed on:

  • Enabling Technologies
  • Pharmaceutical Formulation and Analysis
  • Delivery across Biological Barriers
  • Theranostic Nanomedicines
  • Pharmaceutical Medicine

Explore more about our research by exploring our Seminar Series.